Tech Company Financing Transactions
Pique Therapeutics Funding Round
On 6/10/2009, Pique Therapeutics raised $535 thousand in Series A funding from private investors.
Transaction Overview
Company Name
Announced On
6/10/2009
Transaction Type
Venture Equity
Amount
$535,000
Round
Series A
Investors
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
201 W. Main St. PMB 317 300
Durham, NC 27701
USA
Durham, NC 27701
USA
Phone
Website
Email Address
Overview
Pique Therapeutics is a biotechnology company seeking to become the leading therapeutic vaccine company, focused initially on the treatment of cancer.Pique's lead product is a first-in-class therapeutic vaccine (PT 107) for the treatment of non-small cell lung cancer (NSCLC).
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
President
Christopher Meldrum
Browse more venture capital transactions:
Prev: 6/10/2009: Marina Biotech venture capital transaction
Next: 6/11/2009: Dilithium Networks venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on every notable VC transaction. VC investment data records reported here are sourced from company press releases and news coverage. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs